🇩🇪 EVT.DE — Evotec SE

Salud Mantener
← Volver

Precio actual

2,8860 EUR

Máx. histórico

91,9533

9743 días

Split 2:1 del 18/08/2000

Caída desde máximo

-96,86%

Rango 52 semanas

2,4060 – 7,1600

Variación hoy

+0,91%

Cierre anterior

2,8600

Rango de hoy

2,8420 – 2,9200

Volumen hoy

939.878

Peor caída histórica

-99,40%

02/03/2000 → 02/03/2009

Aún sin recuperar

Volatilidad anualizada ⓘ

59,97%

Información
Nombre completo
Evotec SE
Divisa
EUR
Mercado
XETRA
Sector
Salud
Industria
Drug Manufacturers - Specialty & Generic
Empleados
4.461
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
4,4429 EUR (puede no estar actualizado)
Primera cotización
12/11/1999
Precio actualizado
hace 1 día
Sobre la empresa

Evotec SE operates as a drug discovery and development company in the United States, Germany, France, the United Kingdom, Switzerland, and internationally. It operates in two segments, Shared R&D and Just – Evotec Biologics. The company is developing pharmaceutical products in various therapeutic areas, such as oncology, autoimmune, cancer, diabetes, heart failure, immunology, pain and inflammation, infectious, kidney, liver, respiratory, fibrotic and metabolic diseases, and rare diseases. It is also developingcentral nervous system (CNS) and cardiometabolic diseases; and animal and women health. The company has collaboration agreements with Mass General Brigham and Joslin Diabetes Center focusing on cardiometabolic diseases; BMS antiviral; Novo Nordisk cell therapy; University of Oxford; German Cancer Research Center; University Hospital in Hamburg; University of Toronto, Harvard, and Yale; Johns Hopkins University; Ospedale San Raffaele (OSR); and National University of Singapore. In addition, it has a partnership with LAB282, LAB150, beLAB2122, beLAB1407, LAB eN², Danube Labs, VC Amplitude Ventures, LaB eN2, and 65LAB. Further, the company serves pharma and biotechnology companies, academic institutions, patient advocacy groups, and venture capital. Evotec SE has strategic collaboration with Almirall, S.A. for the development of novel therapeutics for severe skin diseases, including a range of immune-mediated inflammatory conditions. The company collaborate with Odyssey Therapeutics, Inc. to designs and develops AI based discovery platform to discover new treatments in autoimmune and inflammatory diseases. The company was formerly known as Evotec AG and changed its name to Evotec SE in April 2019. Evotec SE was incorporated in 1993 and is headquartered in Hamburg, Germany.

Splits Registrados en el histórico de precios
Fecha Ratio
18/08/2000 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
03/09/2004 2,7039 2,7636 2,6940 2,7039 +1,87% 2,57% 91.176
02/09/2004 2,6244 2,7238 2,6145 2,6542 +1,52% 4,16% 116.379
01/09/2004 2,6145 2,6244 2,5648 2,6145 +1,16% 2,28% 46.572
31/08/2004 2,5648 2,5846 2,5150 2,5846 +0,77% 2,71% 71.152
30/08/2004 2,6840 2,6840 2,5449 2,5648 -4,44% 5,18% 94.452
27/08/2004 2,6542 2,7437 2,6443 2,6840 +0,00% 3,75% 65.570
26/08/2004 2,7337 2,7437 2,6443 2,6840 -1,10% 3,64% 37.118
25/08/2004 2,7437 2,7437 2,6542 2,7139 +0,00% 3,26% 24.576
24/08/2004 2,6840 2,7536 2,6840 2,7139 -0,36% 2,59% 22.628
23/08/2004 2,7536 2,7835 2,7238 2,7238 +0,36% 2,17% 69.735
20/08/2004 2,6840 2,7238 2,6542 2,7139 +0,37% 2,59% 52.492
19/08/2004 2,7835 2,8033 2,6741 2,7039 -1,45% 4,64% 101.075
18/08/2004 2,8829 2,8829 2,5946 2,7437 -2,13% 10,00% 360.417
17/08/2004 2,4952 2,8530 2,4952 2,8033 +13,71% 14,34% 684.238
16/08/2004 2,2168 2,4653 2,2168 2,4653 +11,71% 11,21% 296.977
13/08/2004 2,3162 2,3759 2,1373 2,2069 -10,12% 10,30% 580.619
12/08/2004 2,5747 2,5747 2,3461 2,4554 -4,27% 8,88% 92.108
11/08/2004 2,7735 2,7835 2,4952 2,5648 -7,52% 10,39% 131.137
10/08/2004 2,5946 2,7735 2,5946 2,7735 +5,28% 6,90% 52.864
09/08/2004 2,6642 2,7735 2,4952 2,6343 -1,12% 10,45% 89.463
06/08/2004 2,7636 2,8133 2,6642 2,6642 -5,30% 5,40% 70.441
05/08/2004 2,8232 2,8729 2,7636 2,8133 +1,07% 3,87% 63.512
04/08/2004 2,9326 2,9326 2,7337 2,7835 -4,44% 6,78% 85.751
03/08/2004 2,8928 2,9524 2,8829 2,9127 +0,00% 2,40% 50.027
02/08/2004 2,9226 2,9922 2,9027 2,9127 -0,68% 3,06% 87.918
30/07/2004 2,9326 2,9823 2,8133 2,9326 +0,34% 5,76% 174.004
29/07/2004 2,8729 2,9226 2,7337 2,9226 +3,16% 6,58% 127.856
28/07/2004 2,8729 2,9624 2,7835 2,8332 +3,26% 6,23% 206.282
27/07/2004 3,0519 3,0717 2,7337 2,7437 -8,91% 11,08% 396.901
26/07/2004 3,0519 3,0519 2,9922 3,0121 +0,67% 1,96% 105.261